A UK cleanroom conference addressing key drivers in the cleanroom industry
Wednesday 20 May 2026
Coffee, registration and explore the exhibition
Toni Horsfield, Cleanroom Technology Conference Chair and Founder/ Managing Director of ISO Cleanroom
Mark Wheeler | Commercial Director, Guardtech Cleanrooms
Mark Wheeler will discuss the key aspects surrounding compliance when it comes to designing and manufacturing revolutionary pre-fabricated shipping container facilities for a wide range of applications – notably Healthcare and Pharmaceuticals.
The presentation will provide detail on the different construction considerations that aid compliance, leaning on Guardtech’s string of recent Cleancube projects for the NHS (aseptic compounding and ATMP facilities) and elite Pharma companies.
Morgan Polen, Microrite
Mark Hallworth | Life Sciences Strategic Senior GMP Scientist, Particle Measuring Systems
This presentation, reviews the step in performing an Environmental Monitoring Risk Assessment (EMRA) per chapter 9 of Annex 1. It follows a full review of the process including the steps required for an HACCP review, and then a quantitative FMEA analysis of a clean process. The session will also focus on performing a risk assessment of a Gloveless Isolator, using a tub filling process, this includes some audience participation in the understanding of how risks are perceived and weighted. The process culminates in the location, frequency and type of monitoring required to meet the current Annex 1 initiative and how to balance this within the sites CCS.
Andrea Harman | UK and Ireland based Concept Developer, Ecophon
Cleanroom design aims to stop pollutants in a controlled environment, but one pollutant often slips through, this is noise. In this presentation we take a look, listen and experience how different sounds affect us demonstrating how, as individuals, we perceive sound differently and how noise can have a huge effect on people working and concentrating in a space. We then look at how the acoustic environment can be controlled and adapted to mitigate the effects whilst maintaining compliance to cleanroom standards.
Lesley Taylor | Addmaster
Topic: to be confirmed
Keith Beattie | Director, EECO2
Nick Bancroft | Products & Operations Director, EECO2
Jim Polarine | Principal Consultant, Technical Services, STERIS
This seminar will cover key components of CCS (Contamination Control Strategy) in a recent biopharma disinfectant field trial. The case study utilized a ready to use quaternary ammonium disinfectant and a hydrogen peroxide/peracetic acid sporicide to control bioburden in a new cleanroom operation post construction. Material flow, engineering controls, utility supplies, and operational procedures will be discussed. This presentation will cover new details such as witnessing activities during a disinfectant field trial from the new PDA Technical Report #70. In depth, field trial environmental monitoring data will be covered. This CCS case study has recently been published in Cleanroom Technology Europe.
Panel members to be decided
At the end of Day 1, delegates are invited to test their cleanroom knowledge in a fun quiz while enjoying drinks and informal networking. Finally, this session offers an opportunity for attendees to connect, exchange ideas and reflect on the day’s discussions.
Thursday 21 May 2026
Coffee, registration and explore the exhibition
Stephen Ward, Managing Director at T-SQUARED Validair
Lene Blicher Oleson | Senior Consultant, Niras
Hanna De Neve | Global Marketing Manager, Molnlycke
David Wright | ParticlesPlus
Managing people in and around cleanrooms is often more challenging than managing airflow, filtration, or particle counts. Many organizations have the signs posted, the training completed, and the procedures documented, yet contamination events and compliance gaps still occur. This presentation challenges the assumption that documentation alone creates compliance.
Drawing from firsthand experience overseeing cleanroom compliance at NASA’s Kennedy Space Center, this presentation will explore how complexity, cognitive overload, and human behavior undermines even well-designed systems. Why do operators ignore signs placed directly in front of them? Why do teams who have been trained continue to make the same mistakes over and over again? Why do knowledgeable professionals sometimes choose not to follow the rules?
Through practical anecdotes and human-factors research, this session reframes contamination control as a leadership challenge rather than a documentation problem. It focuses on how communication design, training structure, and verification systems influence real-world behavior. Ultimately, cleanroom performance improves not by adding more instructions, but by aligning communication, training, and compliance with how people actually think and operate.
Aqeel Ahmed | Technical Director, Vetz Pharmaceuticals
Manufacturing cytotoxic and highly potent medicines involves significant risks to workers, the environment, and product quality. Traditional cleanrooms are designed to protect products from contamination but are not always sufficient to safeguard personnel from hazardous drug exposure. Modern pharmaceutical facilities must adopt integrated containment strategies to ensure safety, efficiency, and regulatory compliance.
This presentation highlights practical approaches, including specialised room pressure controls, high-containment isolators, closed-system transfer devices, controlled material and personnel flows, and advanced personal protective equipment (PPE). Real-world examples demonstrate how pharmaceutical companies enhance safety, optimize workflows, and reduce occupational exposure while meeting global standards. Key references include WHO Good Manufacturing Practices for Pharmaceutical Products Containing Hazardous Substances (TRS 957, Annex 3, 2010), USP <800>, EU GMP Annex 1, and ISOPP 2022.
Attendees will also gain insight into future trends, such as modular facility designs, automation, robotics, and digital monitoring systems, supporting safer, versatile, and next-generation cytotoxic manufacturing environments.
Topic: to be confirmed
Panel members to be decided
Akeel Ahmed | Business Development Manager, Kemtile
Gonzague Vallière | Halyard
Glove sustainability is won – or lost – across the lifecycle, not just at waste.
We’ll quantify where impact really occurs (manufacturing energy/water vs. transport/packaging) and translate end of life realities for GMP environments. Then we look ahead: regulatory implications, credible product claims vs. company level badges, and the one or two operational changes that matter most in QA, EHS, and procurement.
Expect trigger questions to connect insights to your site (SOPs, validations, supplier audits) and actionable steps you can take next quarter to reduce risk and footprint without compromising compliance.
Stephen Ward, Managing Director at T-SQUARED Validair